In the CPVT subcohort, 5 index cases were genetically analyzed, identifying 14 genetic variants: 4 in a gene with a definitive clinical validity to CPVT (RYR2) and 9 in genes with no association to CPVT. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.